Endoscopy Operative Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Endoscopy Operative Devices Market Trends and Insights

Surge in Minimally-Invasive GI and Bariatric Procedures

Endoscopic sleeve gastroplasty and intragastric balloon placements exceeded 15,000 combined cases in the United States during 2024 after joint clinical guidelines positioned these interventions as first-line therapy for patients with a body mass index between 30 and 40.^{[1]American Society for Gastrointestinal Endoscopy, “Joint Guidelines on Endoscopic Bariatric Procedures,” asge.org} Device makers responded with pre-loaded suturing patterns that reduce procedure time to less than one hour, enabling ambulatory centers to schedule more bariatric cases per day. European payers followed Germany’s decision to reimburse duodenal-jejunal bypass liners at EUR 3,200 (USD 3,456), giving hospitals a clear commercial path for metabolic endoscopy. These changes bolster procedure volumes, stimulate accessory demand, and reinforce the positive outlook for the endoscopy operative devices market. Manufacturers, therefore, prioritize platforms that streamline sleeve geometry and liner deployment to maintain clinical momentum.

Accelerated Shift of Routine Endoscopy to Outpatient and ASC Settings

Full Medicare payment parity for colonoscopy in ambulatory surgical centers took effect in 2024, and commercial insurers quickly mirrored the policy to steer patients toward lower-cost venues.^{[2]U.S. Centers for Medicare & Medicaid Services, “Medicare-Certified Ambulatory Surgical Centers,” cms.gov} The result was a double-digit rise in ASC-based upper-endoscopies and a move to three-year equipment leases that bundle hardware, software, and disposables into a single monthly invoice. Parallel initiatives are emerging elsewhere: the United Kingdom has earmarked GBP 240 million (USD 312 million) to expand community diagnostic centers, aiming to reduce hospital procedures by 20% by 2027. As a consequence, tower upgrades and accessory sales now hinge on flexible financing and service contracts, keeping the endoscopy operative devices market centered on subscription economics.

Rapid Adoption of Single-Use Endoscopes for Infection Control

The U.S. Food and Drug Administration advised providers in 2024 to transition to disposable duodenoscopes after detecting consistent contamination in reusable models despite proper reprocessing. Boston Scientific and Ambu each launched scopes that replicate the maneuverability of reusable devices while avoiding the need for high-level disinfection. Randomized trials covering more than 4,000 patients reported no difference in procedural success between single-use and reusable colonoscopes, closing the last primary clinical objection to disposables. Hospitals have begun factoring avoided reprocessing labor and capital outlays into procurement decisions, strengthening the cost case for disposables and adding further momentum to the endoscopy operative devices market.

Integration of AI-Assisted Real-Time Lesion Detection

Medtronic’s GI Genius received approval in Japan in 2024 and in China in 2025, opening markets that collectively perform more than 40 million colonoscopies a year.^{[3]Medtronic, “GI Genius AI Platform Approvals,” medtronic.com} Real-time bounding boxes increased adenoma detection rates by double digits in European registries, while Olympus and Fujifilm expanded CE Mark indications to include vascular pattern recognition and histology prediction. Providers are adopting pay-per-use licenses that integrate seamlessly with existing towers, boosting the software’s share of device revenue and prompting incumbents to embed AI updates into long-term service agreements. These dynamics sustain innovation and reinforce strategic stickiness within the endoscopy operative devices market.

Shortage of Skilled Endoscopists and Reprocessing Technicians

The American Gastroenterological Association projects a 14,000-provider shortfall by 2030 because retirements are outpacing fellowship graduations. Rural communities already face six-month waits for screening colonoscopy, while high turnover among reprocessing staff forces urban centers to cancel lucrative therapeutic cases. These staffing shortages constrain capacity even as advances in equipment accelerate, tempering the otherwise strong growth prospects of the endoscopy operative devices market. Health systems are experimenting with virtual pre-procedure teaching and robotic scope steering to mitigate the gap, yet the near-term impact on installed-base utilization remains negative.

High Capital and Maintenance Cost of Advanced Visualization Platforms

Upgrading to 4K towers with AI software and multi-spectral imaging can require USD 180,000-250,000 upfront plus 12-15% annually for service, a hurdle many community hospitals and independent ASCs cannot clear. Return-on-investment models often assume procedure growth that smaller centers rarely achieve. In emerging economies where per-capita spend is below USD 200, older high-definition systems remain in use, delaying replacement cycles and moderating expansion of the endoscopy operative devices market. Vendor financing and pay-per-scan structures are gaining traction, yet price sensitivity continues to curb penetration of top-tier platforms.

Segment Analysis

By Product Type: Energy Platforms Gain on Surgical Precision Mandates

Energy systems recorded the fastest forecast growth at 6.98% from 2026 to 2031 as providers swap monopolar devices for plasma and ultrasonic platforms that cut thermal spread without smoking the field. Olympus Thunderbeat added thoracic clearance in 2024, and Ethicon’s updated Harmonic introduced adaptive tissue sensing in 2025, underscoring a steady flow of iterative improvements. Access devices maintained a 35.31% share in 2025, anchored by legacy trocar fleets and a gradual move toward single-incision ports. GelPOINT now appears in 18% of U.S. laparoscopic colorectal cases, illustrating how disposable seals can reshape workflows. The endoscopy operative devices market for energy systems is projected to grow steadily as hospitals adopt ESG directives that reward low-power alternatives.

Suction and irrigation devices add filtration to capture aerosolized fragments, while hand instruments face price pressure from bundled purchasing. Insufflators have shifted from stand-alone boxes to algorithm-based tower modules that auto-adjust intra-abdominal pressure. Niche categories such as wound retractors and snares ride the wave of natural-orifice surgery, pointing toward incremental yet diversified revenue across the endoscopy operative devices market.

Note: Segment shares of all individual segments available upon report purchase

By Application: Laparoscopy Builds Momentum on Robotic Integration

Gastrointestinal procedures retained 49.57% revenue share in 2025, supported by high screening volumes, but laparoscopy is advancing at a 7.72% CAGR as robotic-assisted colorectal and bariatric cases proliferate. The da Vinci 5 system, launched in 2024, widened access to complex minimally invasive surgery by adding instrument tracking and force feedback that shorten learning curves. Hospitals report 18% year-over-year growth in robotic general surgery, boosting the accessory pull-through vital to the endoscopy operative devices market. Meanwhile, single-use cystoscopes expand office urology, and robotic bronchoscopy extends the reach into peripheral lung nodules, underscoring how diversification of applications sustains demand.

Obstetrics and gynecology endoscopy maintains stable procedure counts, while arthroscopy and other specialties focus on imaging fidelity rather than volume growth. The endoscopy operative devices market share for laparoscopy is expected to climb steadily as reimbursement aligns with improved patient recovery metrics.

By End User: ASC Adoption Accelerates Under Cost-Containment Pressures

Hospitals generated 42.72% of 2025 revenue but face growing competition from ambulatory surgical centers, which are forecast to post an 8.07% CAGR through 2031. Payment parity and tiered insurance benefits make ASCs the preferred venue for screening colonoscopy, routine upper GI scopes, and straightforward laparoscopic procedures. Leasing and per-procedure payment schemes align with ASC capital constraints, prompting vendors to bundle visualization towers with AI updates and disposables into flat monthly fees. This arrangement anchors predictable cash flows while boosting utilization across the endoscopy operative devices market.

Hospitals retain complex therapeutic cases that require ICU backup, anesthesia depth, or overnight monitoring. Specialty clinics, though smaller, deliver high throughput and negotiate direct contracts at favorable discounts, illustrating how varied purchasing behavior across end users influences price realization and competitive positioning within the endoscopy operative devices market.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America commanded a 39.83% share in 2025, aided by Medicare parity, rapid AI clearances, and infrastructure grants for outpatient diagnostic hubs. Bariatric endoscopy grew 28% after new reimbursement codes equalized payments with laparoscopic alternatives, pulling accessory demand into fast-growth territory. Canada and Mexico reinforce regional supply chains as manufacturers reroute assembly from tariff-exposed Chinese plants to North American facilities. These developments underpin a resilient revenue base for the endoscopy operative devices market.

Asia-Pacific is on track for a 9.29% CAGR, the fastest worldwide, as China approved 47 Class III devices in 2024 and India extended national insurance to hundreds of millions more citizens. Domestic Chinese suppliers undercut Japanese incumbents by 40% while still meeting ISO 13485 standards, compressing price bands across flexible scopes. Japan spurred a replacement wave by adding reimbursement for narrow-band imaging, while India’s incentive program lured Fujifilm to Bangalore for camera-head assembly. Medical tourism in South Korea drives premium demand, keeping the endoscopy equipment market diverse and vibrant across the region.

Europe advances steadily despite regulatory drag from the Medical Device Regulation, which lengthens AI approvals by up to 1 year. Germany, the United Kingdom, and France remain the volume anchors, with the U.K. investing USD 312 million to migrate 20% of endoscopies to community diagnostic centers by 2027. The Gulf Cooperation Council fuels Middle East expansion through large hospital projects, while Brazil adds public endoscopy suites, yet struggles with under-reimbursed therapeutic codes. Collectively, these shifts maintain long-term growth prospects for the global endoscopy operative devices market, even as regional hurdles persist.